<DOC>
	<DOCNO>NCT01926990</DOCNO>
	<brief_summary>This pilot clinical trial study perfusion compute tomography ( CT ) predict response treatment patient advance kidney cancer . Comparing result diagnostic procedure do , , target therapy may help doctor predict patient 's response treatment help plan best treatment .</brief_summary>
	<brief_title>Perfusion CT Monitoring Predict Treatment Efficacy Renal Cell Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma , Renal Cell</mesh_term>
	<criteria>Suspected biopsyproven renal cell carcinoma Treatment plan sunitinib , pazopanib , sorafenib , bevacizumab , axitinib , nivolumab alone combination investigational agent Ability understand willingness sign write informed consent document Serum creatinine great equal 1.7 mg/dL Severe allergy contrast agent Any contraindication undergo CT scan Pregnancy unwillingness use preventative measure woman childbearing potential</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>